1. Pulmonary and renal long COVID at two-year revisit
- Author
-
Jing Wang, Xiao Liang, Yufen Zheng, Yi Zhu, Kai Zhou, Xiaomai Wu, Rui Sun, Yifan Hu, Xiaoli Zhu, Hongbo Chi, Shanjun Chen, Mengge Lyu, Yuting Xie, Xiao Yi, Wei Liu, Xue Cai, Sainan Li, Qiushi Zhang, Chunlong Wu, Yingqiu Shi, Donglian Wang, Minfei Peng, Ying Zhang, Huafen Liu, Chao Zhang, Sheng Quan, Ziqing Kong, Zhouyang Kang, Guangjun Zhu, Hongguo Zhu, Shiyong Chen, Junbo Liang, Hai Yang, Jianxin Pang, Yicheng Fang, Haixiao Chen, Jun Li, Jiaqin Xu, Tiannan Guo, and Bo Shen
- Subjects
Respiratory medicine ,Clinical finding ,Omics ,Machine learning ,Science - Abstract
Summary: This study investigated host responses to long COVID by following up with 89 of the original 144 cohorts for 1-year (N = 73) and 2-year visits (N = 57). Pulmonary long COVID, characterized by fibrous stripes, was observed in 8.7% and 17.8% of patients at the 1-year and 2-year revisits, respectively, while renal long COVID was present in 15.2% and 23.9% of patients, respectively. Pulmonary and renal long COVID at 1-year revisit was predicted using a machine learning model based on clinical and multi-omics data collected during the first month of the disease with an accuracy of 87.5%. Proteomics revealed that lung fibrous stripes were associated with consistent down-regulation of surfactant-associated protein B in the sera, while renal long COVID could be linked to the inhibition of urinary protein expression. This study provides a longitudinal view of the clinical and molecular landscape of COVID-19 and presents a predictive model for pulmonary and renal long COVID.
- Published
- 2024
- Full Text
- View/download PDF